Abstract
THE importance of the normal metabolism of long-chain fatty acids has been emphasized by the increasing number of reports of the association of defects in this pathway with serious and even fatal illness.1 , 2 Surprisingly, obvious clinical symptoms are intermittent and associated with intercurrent illness and especially with the need for gluconeogenesis.2 Carnitine palmitoyltransferase catalyzes the transport of long-chain fatty acids into mitochondria, which is the first obligatory step in the oxidation of fatty acids. Biochemical and immunologic analyses and studies of patients with defective fatty-acid oxidation have localized carnitine palmitoyltransferase type 1 to the inner part of the outer mitochondrial . . .
Cite
CITATION STYLE
Falik-Borenstein, Z. C., Jordan, S. C., Saudubray, J.-M., Brivet, M., Demaugre, F., Edmond, J., & Cederbaum, S. D. (1992). Renal Tubular Acidosis in Carnitine Palmitoyltransferase Type 1 Deficiency. New England Journal of Medicine, 327(1), 24–27. https://doi.org/10.1056/nejm199207023270105
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.